Teva Pharmaceutical Industries Limited
$38.98
-$0.21 (-0.54%)
$38.66Day Range$39.38
Key Statistics
Market Cap
$45.46B
Shares Outstanding
1,166.3M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Feb 16, 1982
Round Lot
100
Locale
US
Trading Data
Day Open
$38.90
Day High
$39.38
Day Low
$38.66
Volume
5.48M
VWAP
$39.01
Prev Close
$39.19
Transactions
--
Acc. Volume
--
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
PHARMACEUTICAL PREPARATIONSSIC 283432,842 employeesTEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV972 (3) 914-8213IPO Feb 16, 1982US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000818686
- Ticker Root
- TEVA
- SIC Code
- 2834
About Teva Pharmaceutical Industries Limited (TEVA) Stock
Teva Pharmaceutical Industries Limited (TEVA) closed the 2026-09-18 session at $38.98, down 0.54% versus the previous close (-0.21). The stock opened at $38.90 and traded between $38.66 and $39.38 during that session. Session trading volume was 5.5M shares. The volume-weighted average price (VWAP) is $39.01.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Teva Pharmaceutical Industries Limited has a market capitalization of $45.46 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TEVA is listed on the XNYS exchange. The company employs approximately 32,842 people. The recorded listing date is 1982-02-16.
On this page you can find market TEVA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.